Classification of antidiabetic agents
The pharmacological regulation of carbohydrate metabolism relies on two major categories of drugs. Insulin preparations are used as replacement therapy. The second group consists of synthetic antidiabetic agents intended for oral administration. They differ in their mechanisms of stimulating hormone production.
Sulfonylureas and glinides
This group of drugs stimulates insulin secretion through a direct effect on ion channels. Sulfonylureas and meglitinides (such as nateglinide) target the ATP-sensitive $K^+$ channel located on the $eta$-cell membrane.
- The drugs bind to the channel receptors and forcibly block them, mimicking the action of ATP.
- This results in membrane depolarization and the opening of voltage-gated $Ca^{2+}$ channels, which triggers insulin secretion.
- An important feature is that this process occurs independently of glucose concentration and its metabolism, bypassing the ATP production step.
Incretin mimetics and receptor pathway
An alternative method of stimulating secretion is achieved through the receptor apparatus using incretin mimetics. These include glucagon-like peptide-1 analogues (e.g., exenatide). Their target site is the superficial membrane GLP-1 receptor.
The intracellular cascade includes the following steps:
- Receptor activation triggers the enzyme adenylate cyclase (AC).
- AC stimulates a cascade of reactions involving protein kinases (the PKC pathway).
- Kinases ensure the phosphorylation and closure of ATP-sensitive $K^+$ channels, maintaining depolarization.
- Direct stimulation of exocytosis and release of insulin granules occurs.
The end result of this cascade is the enhancement of specifically glucose-dependent insulin secretion.
Briefly: answers to topical questions
Which specific drugs belong to sulfonylureas?
Sulfonylureas include first- and second-generation drugs.
- First-generation drugs include carbutamide, tolazamide, tolbutamide, and chlorpropamide.
- Second-generation drugs include glibenclamide, gliclazide, glipizide, and gliquidone.
Which drugs belong to the meglitinide group?
The meglitinide group, which comprises prandial glucose regulators, includes the following drugs:
- Nateglinide is a phenylalanine derivative that selectively blocks ATP-sensitive potassium channels of pancreatic beta cells.
- Repaglinide is a drug for controlling postprandial hyperglycemia with a rapid onset of action, suitable for patients with irregular eating habits.
Which drugs belong to glucagon-like peptide-1 analogues?
Glucagon-like peptide-1 (GLP-1) analogues include exenatide.
- Exenatide is an incretin mimetic whose target site is the superficial membrane GLP-1 receptor. Activation of this receptor stimulates adenylate cyclase and triggers a cascade of reactions involving protein kinases. This leads to the closure of ATP-sensitive potassium channels, membrane depolarization, and direct stimulation of insulin granule exocytosis.
Which groups of oral antidiabetic agents increase tissue sensitivity to insulin?
Tissue sensitivity to insulin is increased by two groups of oral antidiabetic agents that reduce insulin resistance:
- Biguanides (the main representative is metformin) reduce insulin resistance of muscle and adipose tissue, as well as hepatic glucose production.
- Thiazolidinediones are insulin sensitizers that reduce insulin resistance in muscle and adipose tissue and hepatic glucose production.
Sulfonylureas "forcibly close" potassium channels independently of glucose, whereas incretins act more subtly via receptors and the adenylate cyclase pathway in a glucose-dependent manner.
Class and exam questions
What are the two main groups of antidiabetic agents?
Insulin preparations for replacement therapy and synthetic oral antidiabetic agents are distinguished.
What is the target site of sulfonylureas?
They act on the ATP-sensitive potassium channel on the beta-cell membrane, forcibly closing it.
What is the feature of incretin mimetics compared to sulfonylureas?
Incretin mimetics enhance glucose-dependent insulin secretion via the receptor apparatus and the adenylate cyclase pathway, whereas sulfonylureas work independently of glucose levels.
What else to study on this topic
- The role of ATP-sensitive potassium channels in regulating beta-cell membrane potential
- Comparison of the mechanisms of action of sulfonylureas and nateglinide
- The role of adenylate cyclase and protein kinases in the incretin cascade
- Mechanisms of insulin granule exocytosis during calcium potentiation
- Differences between glucose-dependent and glucose-independent stimulation of insulin secretion
Master the entire topic in the «Pharmacology» course
This is a summary. The course covers everything tested in classes and exams.
- Complete study guide on "Antidiabetic agents" and 5,304 other subject pages
- Assignments and quizzes after every topic — just like in a colloquium
- AI tutor answers questions on the topic anytime
- 116 video lessons on the subject
Other topics in the section "Hormone preparations, their synthetic substitutes, and antagonists"
Free video lessons: pharmacologyShort lessons with study notes — no registration required.
Prepared by WhiteCoat Pro faculty in accordance with the medical school curriculum. For educational purposes only.